Obstetrics/Gynecology, Kameda Medical Center, Chiba, Japan.
Clinical Research Support Division, Kameda Institute for Health Science, Kameda College of Health Sciences, Chiba, Japan.
J Ultrasound Med. 2024 Oct;43(10):1857-1868. doi: 10.1002/jum.16517. Epub 2024 Jul 2.
This study aimed to validate the diagnostic accuracy of the International Ovarian Tumor Analysis (IOTA) Assessment of Different NEoplasias in the adneXa (ADNEX) model in Japanese women, population with a distinct adnexal mass distribution compared with European women, and to evaluate the model's utility by gynecology trainees and ultrasound specialists.
This single-center, retrospective study analyzed ultrasound data from January 2017 to March 2020 of 206 women with adnexal masses. Patients who underwent ultrasonography and serum CA-125 measurement and received postsurgery histological diagnosis were included. The ADNEX model's diagnostic performance was evaluated by two trainees and two specialists using the area under the receiver operating characteristic curve (AUC) and measures of accuracy, sensitivity, specificity, and predictive values for overall performance and each examiner.
Of the 206 included Japanese women, the prevalence of malignancy was 30.1%, including borderline cases. The overall AUC for distinguishing malignancy was 0.848 (95% confidence interval [CI]: 0.817-0.880). The AUC for each examiner ranged from 0.791 to 0.898, with Specialist 2 showing the highest accuracy and sensitivity varying between 0.677 and 0.839. A moderate degree of agreement was noted among the four examiners (Fleiss' kappa was 0.586). The performance of trainees and specialists differed significantly in evaluating the solid tissue and the papillary projections in both malignant and benign groups (P < .001).
The IOTA ADNEX model effectively differentiates benign and malignant adnexal masses in Japanese women. Although the accuracy matched up moderately among the four examiners, better accuracy is expected with training in evaluating solid tissue and papillary projections.
本研究旨在验证国际卵巢肿瘤分析(IOTA)对不同卵巢肿瘤在日本女性附件中的评估(ADNEX)模型的诊断准确性,日本女性的附件肿块分布与欧洲女性明显不同,并评估该模型在妇科受训者和超声专家中的应用价值。
这是一项单中心、回顾性研究,分析了 2017 年 1 月至 2020 年 3 月期间 206 例附件肿块患者的超声数据。纳入的患者均接受了超声和血清 CA-125 测量,并接受了术后组织学诊断。使用受试者工作特征曲线(AUC)下面积和准确性、敏感性、特异性和预测值等指标,由两名受训者和两名专家评估 ADNEX 模型的诊断性能。
在 206 名纳入的日本女性中,恶性肿瘤的患病率为 30.1%,包括交界性病例。总体而言,区分良恶性肿瘤的 AUC 为 0.848(95%置信区间[CI]:0.817-0.880)。每位检查者的 AUC 范围为 0.791 至 0.898,专家 2 的准确性和敏感性最高,分别为 0.677 至 0.839。四名检查者之间存在中度一致性(Fleiss'kappa 为 0.586)。受训者和专家在评估良恶性肿瘤的实性组织和乳头状突起方面的表现存在显著差异(P < .001)。
IOTA ADNEX 模型可有效区分日本女性的良性和恶性附件肿块。尽管四位检查者的准确性中等,但通过培训评估实性组织和乳头状突起,准确性有望提高。